Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPM1002 vs BCG in Newborns for TB Prevention
NCT04351685Phase 3Completed
- Sponsor
- Serum Institute of India
- Start
- Nov 2020
- Primary completion
- Oct 2024
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 5
01
Overview
A Phase 3 trial of VPM1002 in Tuberculosis (TB), sponsored by Serum Institute of India. Started Nov 2020; status: completed.
02
Drugs
VPM1002
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04351685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351685.